Rothschild Investment LLC’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,500
| Closed | -$378K | – | 501 |
|
|
2022
Q3 | $378K | Sell |
2,500
-3,900
| -61% | -$590K | 0.04% | 320 |
|
|
2022
Q2 | $933K | Sell |
6,400
-3,800
| -37% | -$554K | 0.09% | 221 |
|
|
2022
Q1 | $1.21M | Sell |
10,200
-150
| -1% | -$17.8K | 0.1% | 200 |
|
|
2021
Q4 | $1.43M | Sell |
10,350
-200
| -2% | -$27.6K | 0.11% | 178 |
|
|
2021
Q3 | $1.47M | Sell |
10,550
-1,250
| -11% | -$174K | 0.12% | 166 |
|
|
2021
Q2 | $1.15M | Buy |
11,800
+2,200
| +23% | +$214K | 0.09% | 208 |
|
|
2021
Q1 | $656K | Buy |
9,600
+4,500
| +88% | +$308K | 0.06% | 267 |
|
|
2020
Q4 | $437K | Buy |
+5,100
| New | +$437K | 0.04% | 308 |
|
|
2020
Q3 | – | Sell |
-2,800
| Closed | -$205K | – | 464 |
|
|
2020
Q2 | $205K | Buy |
+2,800
| New | +$205K | 0.02% | 381 |
|